|
2025-03-04 |
2025-03-03 |
V
Verkauf
|
Leonard Frank X
EVP, Pres., Novocure Oncology
Führungsperson
|
2.527
-1.7%
18,54
46.841 USD
|
2.527
-1.7%
|
18,54
|
46.841 USD
|
|
|
2025-03-04 |
2025-03-03 |
V
Verkauf
|
Paravasthu Mukund
Chief Operating Officer
Führungsperson
|
250
-0.8%
18,54
4.634 USD
|
250
-0.8%
|
18,54
|
4.634 USD
|
|
|
2025-03-04 |
2025-03-03 |
V
Verkauf
|
Weinberg Uri
Chief Innovation Officer
Führungsperson
|
268
-0.2%
18,92
5.071 USD
|
268
-0.2%
|
18,92
|
5.071 USD
|
|
|
2025-03-04 |
2025-03-03 |
V
Verkauf
|
Cordova Ashley
Chief Executive Officer
Führungsperson
|
2.053
-1.0%
18,54
38.055 USD
|
2.053
-1.0%
|
18,54
|
38.055 USD
|
|
|
2025-03-03 |
2025-02-28 |
V
Verkauf
|
Leonard Frank X
EVP, Pres., Novocure Oncology
Führungsperson
|
2.770
-1.9%
18,28
50.648 USD
|
2.770
-1.9%
|
18,28
|
50.648 USD
|
|
|
2025-03-03 |
2025-02-28 |
V
Verkauf
|
Paravasthu Mukund
Chief Operating Officer
Führungsperson
|
368
-1.2%
18,28
6.729 USD
|
368
-1.2%
|
18,28
|
6.729 USD
|
|
|
2025-03-03 |
2025-02-28 |
V
Verkauf
|
Weinberg Uri
Chief Innovation Officer
Führungsperson
|
311
-0.2%
18,31
5.695 USD
|
311
-0.2%
|
18,31
|
5.695 USD
|
|
|
2025-03-03 |
2025-02-28 |
V
Verkauf
|
Weinberg Uri
Chief Innovation Officer
Führungsperson
|
4.326
-2.5%
18,78
81.254 USD
|
4.326
-2.5%
|
18,78
|
81.254 USD
|
|
|
2025-03-03 |
2025-02-28 |
V
Verkauf
|
Cordova Ashley
Chief Executive Officer
Führungsperson
|
2.341
-1.1%
18,28
42.804 USD
|
2.341
-1.1%
|
18,28
|
42.804 USD
|
|
|
2025-03-03 |
2025-02-27 |
V
Verkauf
|
Leupin Nicolas
Chief Medical Officer
Führungsperson
|
161
-0.3%
20,55
3.308 USD
|
161
-0.3%
|
20,55
|
3.308 USD
|
|
|
2025-03-03 |
2025-02-27 |
V
Verkauf
|
Leupin Nicolas
Chief Medical Officer
Führungsperson
|
830
-1.6%
19,92
16.535 USD
|
830
-1.6%
|
19,92
|
16.535 USD
|
|
|
2025-03-03 |
2025-02-27 |
V
Verkauf
|
Puri Michal Nath
Chief Human Resources Officer
Führungsperson
|
225
-0.2%
20,55
4.624 USD
|
225
-0.2%
|
20,55
|
4.624 USD
|
|
|
2025-03-03 |
2025-02-27 |
V
Verkauf
|
Puri Michal Nath
Chief Human Resources Officer
Führungsperson
|
1.162
-1.1%
19,92
23.149 USD
|
1.162
-1.1%
|
19,92
|
23.149 USD
|
|
|
2025-03-03 |
2025-02-27 |
V
Verkauf
|
Leonard Frank X
EVP, Pres., Novocure Oncology
Führungsperson
|
1.989
-1.3%
20,55
40.872 USD
|
1.989
-1.3%
|
20,55
|
40.872 USD
|
|
|
2025-03-03 |
2025-02-27 |
V
Verkauf
|
Leonard Frank X
EVP, Pres., Novocure Oncology
Führungsperson
|
10.277
-6.4%
19,92
204.737 USD
|
10.277
-6.4%
|
19,92
|
204.737 USD
|
|
|
2025-03-03 |
2025-02-27 |
V
Verkauf
|
Paravasthu Mukund
Chief Operating Officer
Führungsperson
|
267
-0.9%
20,55
5.487 USD
|
267
-0.9%
|
20,55
|
5.487 USD
|
|
|
2025-03-03 |
2025-02-27 |
V
Verkauf
|
Paravasthu Mukund
Chief Operating Officer
Führungsperson
|
1.379
-4.4%
19,92
27.472 USD
|
1.379
-4.4%
|
19,92
|
27.472 USD
|
|
|
2025-03-03 |
2025-02-27 |
V
Verkauf
|
Cordova Ashley
Chief Executive Officer
Führungsperson
|
1.808
-0.9%
20,55
37.153 USD
|
1.808
-0.9%
|
20,55
|
37.153 USD
|
|
|
2025-03-03 |
2025-02-27 |
V
Verkauf
|
Cordova Ashley
Chief Executive Officer
Führungsperson
|
9.345
-4.3%
19,92
186.170 USD
|
9.345
-4.3%
|
19,92
|
186.170 USD
|
|
|
2025-01-15 |
2025-01-11 |
V
Verkauf
|
Paravasthu Mukund
Chief Operating Officer
Führungsperson
|
2.160
-6.4%
26,81
57.906 USD
|
2.160
-6.4%
|
26,81
|
57.906 USD
|
|
|
2024-11-06 |
2024-11-02 |
V
Verkauf
|
Paravasthu Mukund
Chief Operating Officer
Führungsperson
|
44
-1.3%
16,69
734 USD
|
44
-1.3%
|
16,69
|
734 USD
|
|
|
2024-11-04 |
2024-11-01 |
V
Verkauf
|
Paravasthu Mukund
Chief Operating Officer
Führungsperson
|
160
-4.4%
15,88
2.540 USD
|
160
-4.4%
|
15,88
|
2.540 USD
|
|
|
2024-11-04 |
2024-11-01 |
V
Verkauf
|
Leonard Frank X
EVP, Pres., Novocure Oncology
Führungsperson
|
598
-0.4%
15,94
9.531 USD
|
598
-0.4%
|
15,94
|
9.531 USD
|
|
|
2024-11-04 |
2024-10-31 |
V
Verkauf
|
Puri Michal Nath
Chief Human Resources Officer
Führungsperson
|
810
-0.7%
15,79
12.792 USD
|
810
-0.7%
|
15,79
|
12.792 USD
|
|
|
2024-08-05 |
2024-08-02 |
V
Verkauf
|
Cordova Ashley
Chief Financial Officer
Führungsperson
|
688
-0.3%
20,14
13.857 USD
|
688
-0.3%
|
20,14
|
13.857 USD
|
|
|
2024-06-06 |
2024-06-04 |
V
Verkauf
|
Scannell Timothy J
Nicht geschäftsführender Verwaltungsratsmitglied
|
964
-24.5%
23,89
23.027 USD
|
964
-24.5%
|
23,89
|
23.027 USD
|
|
|
2024-06-06 |
2024-06-04 |
V
Verkauf
|
VERNON W ANTHONY
Nicht geschäftsführender Verwaltungsratsmitglied
|
964
-0.6%
23,89
23.033 USD
|
964
-0.6%
|
23,89
|
23.033 USD
|
|
|
2024-06-06 |
2024-06-04 |
V
Verkauf
|
LEUNG GABRIEL
Nicht geschäftsführender Verwaltungsratsmitglied
|
964
-1.2%
23,89
23.025 USD
|
964
-1.2%
|
23,89
|
23.025 USD
|
|
|
2024-03-05 |
2024-03-04 |
V
Verkauf
|
Leonard Frank X
EVP, Pres., Novocure Oncology
Führungsperson
|
840
-0.5%
16,01
13.448 USD
|
840
-0.5%
|
16,01
|
13.448 USD
|
|
|
2024-03-05 |
2024-03-04 |
V
Verkauf
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Führungsperson
|
1.217
-0.5%
16,01
19.484 USD
|
1.217
-0.5%
|
16,01
|
19.484 USD
|
|
|
2024-03-05 |
2024-03-01 |
V
Verkauf
|
Leonard Frank X
EVP, Pres., Novocure Oncology
Führungsperson
|
1.679
-1.0%
16,03
26.909 USD
|
1.679
-1.0%
|
16,03
|
26.909 USD
|
|
|
2024-03-05 |
2024-03-01 |
V
Verkauf
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Führungsperson
|
2.107
-0.8%
16,03
33.769 USD
|
2.107
-0.8%
|
16,03
|
33.769 USD
|
|
|
2024-02-29 |
2024-02-28 |
V
Verkauf
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Führungsperson
|
2.303
-0.9%
16,14
37.177 USD
|
2.303
-0.9%
|
16,14
|
37.177 USD
|
|
|
2024-02-29 |
2024-02-28 |
V
Verkauf
|
Leonard Frank X
EVP, Pres., Novocure Oncology
Führungsperson
|
2.078
-1.3%
16,14
33.545 USD
|
2.078
-1.3%
|
16,14
|
33.545 USD
|
|
|
2023-11-08 |
2023-11-07 |
GV
Geplanter Verkauf
|
Shah Pritesh
Chief Growth Officer
Führungsperson
|
382
-0.3%
12,65
4.832 USD
|
382
-0.3%
|
12,65
|
4.832 USD
|
|
|
2023-09-05 |
2023-09-01 |
V
Verkauf
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Führungsperson
|
294
-0.1%
21,82
6.414 USD
|
294
-0.1%
|
21,82
|
6.414 USD
|
|
|
2023-09-05 |
2023-09-01 |
V
Verkauf
|
Shah Pritesh
Chief Growth Officer
Führungsperson
|
273
-0.2%
21,82
5.956 USD
|
273
-0.2%
|
21,82
|
5.956 USD
|
|
|
2023-09-05 |
2023-09-01 |
V
Verkauf
|
Cordova Ashley
Chief Financial Officer
Führungsperson
|
883
-0.9%
21,82
19.265 USD
|
883
-0.9%
|
21,82
|
19.265 USD
|
|
|
2023-08-04 |
2023-08-02 |
V
Verkauf
|
Cordova Ashley
Chief Financial Officer
Führungsperson
|
1.144
-1.1%
30,25
34.607 USD
|
1.144
-1.1%
|
30,25
|
34.607 USD
|
|
|
2023-03-07 |
2023-03-07 |
GV
Geplanter Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
2.315
-4.1%
75,59
174.999 USD
|
2.315
-4.1%
|
75,59
|
174.999 USD
|
|
|
2023-03-07 |
2023-03-07 |
GV
Geplanter Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
6.003
-9.6%
75,00
450.206 USD
|
6.003
-9.6%
|
75,00
|
450.206 USD
|
|
|
2023-03-07 |
2023-03-03 |
V
Verkauf
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Führungsperson
|
20.415
-8.9%
76,16
1.554.794 USD
|
20.415
-8.9%
|
76,16
|
1.554.794 USD
|
|
|
2023-03-07 |
2023-03-03 |
V
Verkauf
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Führungsperson
|
1.692
-0.7%
76,16
128.862 USD
|
1.692
-0.7%
|
76,16
|
128.862 USD
|
|
|
2023-03-07 |
2023-03-03 |
V
Verkauf
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Führungsperson
|
3.528
-1.5%
76,16
268.690 USD
|
3.528
-1.5%
|
76,16
|
268.690 USD
|
|
|
2023-03-07 |
2023-03-03 |
V
Verkauf
|
Shah Pritesh
Chief Growth Officer
Führungsperson
|
16.909
-11.9%
76,16
1.287.779 USD
|
16.909
-11.9%
|
76,16
|
1.287.779 USD
|
|
|
2023-03-07 |
2023-03-03 |
V
Verkauf
|
Shah Pritesh
Chief Growth Officer
Führungsperson
|
2.942
-2.0%
76,16
224.061 USD
|
2.942
-2.0%
|
76,16
|
224.061 USD
|
|
|
2023-03-07 |
2023-03-03 |
V
Verkauf
|
Shah Pritesh
Chief Growth Officer
Führungsperson
|
1.570
-1.1%
76,16
119.570 USD
|
1.570
-1.1%
|
76,16
|
119.570 USD
|
|
|
2023-03-07 |
2023-03-03 |
V
Verkauf
|
Burke William Patrick
Chief Human Resources Officer
Führungsperson
|
593
-0.9%
76,16
45.163 USD
|
593
-0.9%
|
76,16
|
45.163 USD
|
|
|
2023-03-07 |
2023-03-03 |
V
Verkauf
|
Cordova Ashley
Chief Financial Officer
Führungsperson
|
775
-0.8%
76,16
59.024 USD
|
775
-0.8%
|
76,16
|
59.024 USD
|
|
|
2023-03-07 |
2023-03-03 |
V
Verkauf
|
Cordova Ashley
Chief Financial Officer
Führungsperson
|
4.730
-4.4%
76,16
360.234 USD
|
4.730
-4.4%
|
76,16
|
360.234 USD
|
|
|
2023-03-07 |
2023-03-03 |
V
Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
888
-1.4%
76,16
67.630 USD
|
888
-1.4%
|
76,16
|
67.630 USD
|
|
|
2023-03-07 |
2023-03-03 |
V
Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
4.403
-6.5%
76,16
335.330 USD
|
4.403
-6.5%
|
76,16
|
335.330 USD
|
|
|
2023-03-06 |
2023-03-03 |
GV
Geplanter Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
2.059
-2.9%
77,64
159.859 USD
|
2.059
-2.9%
|
77,64
|
159.859 USD
|
|
|
2023-03-06 |
2023-03-02 |
V
Verkauf
|
Burke William Patrick
Chief Human Resources Officer
Führungsperson
|
281
-0.4%
75,28
21.153 USD
|
281
-0.4%
|
75,28
|
21.153 USD
|
|
|
2023-03-06 |
2023-03-02 |
V
Verkauf
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Führungsperson
|
1.213
-0.7%
75,28
91.312 USD
|
1.213
-0.7%
|
75,28
|
91.312 USD
|
|
|
2023-03-06 |
2023-03-02 |
V
Verkauf
|
Cordova Ashley
Chief Financial Officer
Führungsperson
|
1.055
-1.1%
75,28
79.418 USD
|
1.055
-1.1%
|
75,28
|
79.418 USD
|
|
|
2023-03-06 |
2023-03-02 |
V
Verkauf
|
Shah Pritesh
Chief Growth Officer
Führungsperson
|
937
-0.9%
75,28
70.535 USD
|
937
-0.9%
|
75,28
|
70.535 USD
|
|
|
2023-03-06 |
2023-03-02 |
V
Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
844
-1.4%
75,28
63.535 USD
|
844
-1.4%
|
75,28
|
63.535 USD
|
|
|
2023-03-03 |
2023-03-02 |
GV
Geplanter Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
308
-0.5%
76,05
23.424 USD
|
308
-0.5%
|
76,05
|
23.424 USD
|
|
|
2023-03-03 |
2023-03-02 |
GV
Geplanter Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
3.799
-6.0%
75,32
286.154 USD
|
3.799
-6.0%
|
75,32
|
286.154 USD
|
|
|
2023-03-02 |
2023-03-01 |
V
Verkauf
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Führungsperson
|
2.164
-1.2%
76,36
165.248 USD
|
2.164
-1.2%
|
76,36
|
165.248 USD
|
|
|
2023-03-02 |
2023-03-01 |
V
Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
1.684
-2.6%
76,36
128.594 USD
|
1.684
-2.6%
|
76,36
|
128.594 USD
|
|
|
2023-03-02 |
2023-03-01 |
V
Verkauf
|
Shah Pritesh
Chief Growth Officer
Führungsperson
|
1.923
-1.9%
76,36
146.845 USD
|
1.923
-1.9%
|
76,36
|
146.845 USD
|
|
|
2023-03-02 |
2023-03-01 |
V
Verkauf
|
Cordova Ashley
Chief Financial Officer
Führungsperson
|
2.198
-2.2%
76,36
167.845 USD
|
2.198
-2.2%
|
76,36
|
167.845 USD
|
|
|
2023-03-02 |
2023-03-01 |
V
Verkauf
|
Burke William Patrick
Chief Human Resources Officer
Führungsperson
|
755
-1.1%
76,36
57.654 USD
|
755
-1.1%
|
76,36
|
57.654 USD
|
|
|
2023-01-09 |
2023-01-05 |
V
Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
7.183
-13.5%
120,00
861.960 USD
|
7.183
-13.5%
|
120,00
|
861.960 USD
|
|
|
2023-01-09 |
2023-01-05 |
GV
Geplanter Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
7.183
-13.5%
114,00
818.863 USD
|
7.183
-13.5%
|
114,00
|
818.863 USD
|
|
|
2023-01-09 |
2023-01-05 |
V
Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
5.517
-10.7%
108,00
595.836 USD
|
5.517
-10.7%
|
108,00
|
595.836 USD
|
|
|
2023-01-09 |
2023-01-05 |
V
Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
7.500
-14.0%
108,00
810.000 USD
|
7.500
-14.0%
|
108,00
|
810.000 USD
|
|
|
2023-01-09 |
2023-01-05 |
V
Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
7.826
-14.5%
108,00
845.208 USD
|
7.826
-14.5%
|
108,00
|
845.208 USD
|
|
|
2023-01-09 |
2023-01-05 |
V
Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
1.010
-2.1%
117,00
118.170 USD
|
1.010
-2.1%
|
117,00
|
118.170 USD
|
|
|
2023-01-09 |
2023-01-05 |
GV
Geplanter Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
526
-1.1%
115,03
60.508 USD
|
526
-1.1%
|
115,03
|
60.508 USD
|
|
|
2023-01-09 |
2023-01-05 |
V
Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
417
-0.9%
108,00
45.036 USD
|
417
-0.9%
|
108,00
|
45.036 USD
|
|
|
2023-01-09 |
2023-01-05 |
GV
Geplanter Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
2.345
-4.6%
119,01
279.073 USD
|
2.345
-4.6%
|
119,01
|
279.073 USD
|
|
|
2023-01-09 |
2023-01-05 |
V
Verkauf
|
Weinberg Uri
Chief Science Officer
Führungsperson
|
1.201
-2.7%
120,00
144.120 USD
|
1.201
-2.7%
|
120,00
|
144.120 USD
|
|
